Purpose Despite recommendations, only a proportion of long-term childhood cancer survivors attend follow-up care. We aimed to (1) describe the follow-up attendance of young survivors aged 11-17 years; (2) describe the parental involvement in follow-up, and (3) investigate predictors of follow-up attendance and parental involvement. Methods As part of the Swiss Childhood Cancer Survivor Study, a follow-up questionnaire was sent to parents of childhood cancer survivors aged 11-17 years. We assessed followup attendance of the child, parents' involvement in follow-up, illness perception (Brief IPQ), and sociodemographic data.
Introduction
Risk-based follow-up care is important for childhood cancer survivors to identify and treat late effects [1] [2] [3] . Due to their high risk for medical late effects such as cardiovascular or neurological complications and second malignancies, guidelines have been developed to provide recommendations for risk-stratified long-term follow-up care [4] [5] [6] . These guidelines aimed to increase the awareness of potential late effects, standardize follow-up across different medical specialists involved, and increase follow-up attendance of survivors. Despite these recommendations, only around 20-40 % of adolescent and adult long-term survivors are in long-term follow-up in Switzerland [7] [8] [9] . Factors associated with attendance were younger age at study, older age at diagnosis, and higher risk of treatment-related late effects [7] . Only one study from the USA reported that young survivors between the completion of treatment and 5 years post-diagnosis were less likely to attend follow-up if being male, having a brain tumor, longer time off treatment, and greater distance from hospital [10] .
Parents play an important role in follow-up care of young survivors and are expected to be actively involved [11] . With children, they are the caretakers and provide practical support, such as transportation to appointments. In addition, adult childhood cancer survivors are frequently accompanied by their mothers to follow-up visits. Reasons for this included concerns for health and well-being of their child, parental duty, personal interest, and companionship [12] . Two studies showed that parents accompanied young adult survivors to follow-up care because of concerns about their child's overall health and cancer recurrence [13, 14] . We assume that parental involvement is influenced by their emotional state and how much they are affected by the illness. Follow-up care might provide an opportunity for parents to discuss their concerns and worries. However, there are no studies investigating the follow-up attendance and parental involvement in follow-up care of young survivors of childhood cancer (aged below 18 years) with regards to the opportunity of education to emphasize the importance of follow-up care.
We aimed to (1) describe the current follow-up care of young childhood cancer survivors (aged 11-17 years) in Switzerland, including specialists visited and reasons for non-attendance; (2) describe parental involvement in followup care, and (3) investigate associations of follow-up attendance and parental involvement with clinical characteristics of the child, sociodemographic characteristics of parents, and parents' illness perception.
Methods

Sample and procedure
The Swiss Childhood Cancer Registry (SCCR) is a population-based registry including all cancer patients younger than 21 years and Swiss residents at diagnosis, who were diagnosed with leukemia, lymphoma, central nervous system (CNS) tumors, malignant solid tumors, or Langerhans cell histiocytosis [15, 16] . The Swiss Childhood Cancer Survivor Study (SCCSS) is an ongoing, nationwide, long-term survey which includes a baseline questionnaire (years 2007-2012) and a subsequent follow-up questionnaire (years 2010-2012).
The baseline questionnaire included all patients registered in the SCCR who were diagnosed between 1976 and 2005, aged below 16 years, and having survived for at least 5 years [17] . Parents of survivors aged ≤15 years completed the questionnaire for their children, whereas survivors 16+ years completed their own questionnaire. They received an initial information letter about the study from their former treating hospital. Ten days later, they received a questionnaire with a prepaid return envelope. Non-responders were sent another questionnaire 4-6 weeks later. If they did not reply, they were personally contacted by phone.
The follow-up survey was performed approximately 1-3 years later. To collect the data reported in this paper, a questionnaire was sent to all parents who had responded to the baseline questionnaire and whose child was aged 11-17 years at time of study (n = 306; Supplemental Fig. 1 ). The parent who had completed the baseline questionnaire was contacted again and received the questionnaire with a prepaid return envelope. Those who did not reply within 2 months received a reminder with another questionnaire and prepaid return envelope. Questionnaires were available in German and French. Ethics approval was provided through the general cancer registry permission of the SCCR (The Swiss Federal Commission of Experts for Professional Secrecy in Medical Research). Additionally, we received a non-obstat statement from the ethics committee of the canton of Bern declaring that the ethics committee did not object to the conduct of the study. Participants gave implied informed consent for the study by returning the completed questionnaire.
Measurements
Outcomes assessed in the follow-up questionnaire Follow-up care attendance In Switzerland, childhood cancer survivors are regularly followed-up by their pediatric oncologist for 10 years after diagnosis often into their early twenties and are then usually discharged to a general practitioner (GP) or medical oncologist. Others may continue follow-up with their pediatric oncologist longer into adulthood. If discharged from pediatric oncology, further follow-up is poorly standardized. In younger survivors, a parent usually attends follow-up appointments together with their child. However, as part of transition, most clinicians will have private appointments with the survivor only. We asked parents if their child still attended follow-up: (1) 'yes, my child still attends regular follow-up appointments'; (2) 'yes, my child still has irregular follow-up appointments'; (3) 'no, regular follow-up is completed, but my child goes to the doctor for any cancer-associated complications; (4) 'no, regular follow-up is completed and my child has not seen the doctor for a while'. For the analysis, a binary variable was created: attenders (responses 1 or 2) and nonattenders (responses 3 or 4).
Parents of attenders were asked how frequently their child attends follow-up care (several times a year; once a year; every 2-3 years; and every 4-5 years) and to indicate the healthcare provider on a list including general practitioner, pediatric oncologist, adult oncologist, radiotherapist, gynecologist, psychologist, endocrinologist, and any other healthcare providers.
Parents of survivors only seeing a doctor for cancerassociated complications were asked which doctor they would visit in case of problems. The same list of specialists as described above was provided. Parents of survivors who had stopped attending follow-up seeing only a GP could give reasons why 'child was officially discharged ', 'child lives too far from a follow-up possibility', 'child is afraid that late effects could be detected', 'child does not want to visit a children's hospital', and 'child thinks follow-up is unimportant'. Parents of non-attenders were asked the year of follow-up completion.
Parental involvement Parents were asked whether they are currently involved in follow-up care of their child: (yes/no).
Explanatory variables assessed by questionnaire
We assessed parents' sex, age at study, migration background, language region, parents' education and employment status, and parents' overall information needs. Parents were classified as having a migration background if they were not Swiss citizens by birth or not born in Switzerland. Language region was divided into German and French. Parents' education was divided into three categories: primary (compulsory schooling only); secondary (including vocational training, teachers, technical, commercial schools, etc.); and tertiary (including university) [18] . Employment status was coded as employed (yes/no).
We also included an adapted version of the Brief Illness Perception Questionnaire (Brief IPQ) [19] . The Brief IPQ is a theoretically derived instrument providing information about components underlying the cognitive representation of the illness. We adapted the questions to parents of childhood cancer survivors as proposed in the manual of the IPQ. We wanted to assess how the former cancer disease and possible late effects still affect parents. Parents could express their accordance on an 11-point scale (0 = absolutely not, 10 = absolutely) for the following items: cognitive illness representations-consequences (how much do the consequences of your child's illness affect your life?), timeline (how long do you think the consequences of the child's illness will continue?), personal control (how much control do you feel you have over the consequences of your child's illness?), treatment control (how much do you think follow-up care can help with late effects of your child?), and identity (how often does your child experience symptoms from the illness consequences?); emotional representations-concerns (how concerned are you about your child's illness?) and emotions (how much do the child's illness consequences affect you emotionally?); and illness comprehensibility (how well do you feel you understand your child's illness consequences?). Parents could indicate their current information needs in the following domains: illness, treatment, follow-up, and late effects (yes/no). For the analysis, a binary variable was created: parents' overall information needs (yes or no) [20] .
From the baseline questionnaire of the SCCSS, we extracted information about parent-reported late effects on the survivor (yes/no) [17] .
Clinical variables extracted from the Swiss Childhood cancer registry We extracted the medical information on diagnosis and treatment of the child from the SCCR: cancer diagnosis, cancer treatment, type of treating hospital, age at study, time since diagnosis, and relapse. We classified diagnosis according to the International Classification of Childhood Cancer (third edition) [21] . For analyses, we grouped diagnoses into six major categories: leukemia, lymphoma, CNS tumors, neuroblastoma, bone/soft tissue sarcoma (STS), and other tumors. Treatment was coded as surgery only, chemotherapy (without radiotherapy but may have had surgery), radiotherapy (may have had surgery and/or chemotherapy), and stem cell transplantation (SCT; may have had surgery and/or chemotherapy and/or radiotherapy). The type of treating hospital was divided into university hospital and regional hospital. Relapse was coded yes or no.
Analyses
All analyses were performed using Stata 13.1. We used descriptive statistics, chi-square statistics, and t tests to describe the study population, current follow-up care, and parental involvement. We used univariable and multivariable logistic regression models to analyze associations of clinical characteristics, sociodemographic characteristics, and illness perception with follow-up attendance and parental involvement. The variables age at study, child's age at study, and time since diagnosis were centered around the mean for the regression analyses. In the multivariable model, we included all variables that were statistically significant at p < 0.05 in the univariable model. We used likelihood ratio tests to calculate p values in the multivariable regression models. For the cumulative follow-up attendance analyses, follow-up time was calculated from date of diagnosis until the date of follow-up completion or date of questionnaire completion if survivor was still in follow-up. Cox proportional hazards regression model was used to calculate the cumulative follow-up attendance over time since diagnosis adjusted for age at study and time since diagnosis and shown in a Kaplan-Meier estimation curve. 
Results
Of the 306 eligible parents, we traced and contacted 284 (Supplemental Fig. 2 ). Of those, 189 (67 %) responded. The mean age of the parents was 46.1 years (SD = 4.8, range 33.5-59.5 years), mean time since diagnosis 11.3 years (SD = 2.5, range 6.8-17.2), and mean age of the child at study completion was 14.7 years (SD = 1.8, range 10.7-18.0 years; Table 1 ). Most children were diagnosed with leukemia (39.2 %), followed by CNS tumors (18.0 %), and lymphomas (8.5 %). Participating and non-participating parents were similar regarding language region of Switzerland, cancer type, treatment received, type of treating hospital, child's age at diagnosis, time since diagnosis, relapse status, and parentreported late effects.
Follow-up care attendance Most parents (n = 141, 74.6 %) reported that their child still attended follow-up either regularly (n = 117, 61.9 %) or irregularly (n = 24, 12.7 %; Fig. 1 ). Specialists most often seen for follow-up care were pediatric oncologists (n = 111/141, 78.7 %), endocrinologists (n = 24/ 141, 17.0 %), and general practitioners (n = 22/141, 15.6 %). Among non-attenders, 11 (23 %) reported that they only ever see a doctor when a complication has occurred and 37 (77 %) reported that they had completed follow-up care.
Among those seeing a doctor only for cancer-associated complications, eight (72.7 %) reported visiting a general practitioner and three (27.3 %) a pediatric oncologist. Parents of children who completed follow-up gave the following reasons: child was officially discharged (n = 33, 89.2 %), child thinks follow-up care is unimportant (n = 3, 8.1 %), and child does not want to visit a children's hospital (n = 1, 2.7 %).
Parental involvement in follow-up care Most parents reported that they were involved in follow-up care (n = 130, 92.2 % of 141).
Factors associated with non-attendance We compared associations between not attending/attending follow-up and clinical, sociodemographic variables, and parents' illness perception. In the univariable and Cox regression, non-attenders were older than attenders (OR = 1.50, CI = 1.22-1.85; p = 0.001; Table 2 ) and diagnosed a longer time ago (OR = 1.34, CI = 1.16-1.55; p = 0.001; Fig. 2 ). Regular visits were reported more frequently in younger age groups (Fig. 1) . Parents of non-attenders reported lower treatment control (they did not think that follow-up could help with late effects; IPQ item 4, OR = 0.86, CI = 0.79-0.96, p = 0.005). In the multivariable regression older age at study (OR = 1.32, CI = 1.03-1.69, p = 0.024), longer time since diagnosis Non-attenders who were officially discharged and nonattenders with other reasons were similar in sociodemographic characteristics and clinical factors. The only difference was that those who were officially discharged were more likely to be older (p = 0.040; data not shown) and had parents with lower perceived treatment control (p = 0.041). 
Discussion
This is one of the first studies looking at follow-up attendance and parental involvement in young survivors of childhood cancer. We found that three out of four 11-17 year old survivors still attended follow-up care; however, the number decreased with age such that only half of the survivors aged 15 years or older still attended follow-up care. The specialists most often visited were pediatric oncologists followed by endocrinologists and general practitioners. As expected, attendance decreased with longer time since diagnosis and increasing age of survivor. The majority of parents reported that they were involved in follow-up care of their child. Parents of non-attenders reported lower treatment control. Parents with higher information needs were more likely to be involved in follow-up.
Survivors diagnosed a longer time ago and who were older at the time of study were less likely to attend follow-up. This is in line with other studies which focused on young survivors [10] or on adolescent or adult survivors [7-9, 22, 23] . This can be hazardous because the likelihood of late effects and second malignancies increases with time since diagnosis [3] . Even 45 years after diagnosis, survivors were at higher risk of premature death due to second cancers or severe cardiac or respiratory events [24] . Therefore, lifelong follow-up care is often recommended [25] . However, follow-up care in Switzerland is usually organized by pediatric oncologist and older survivors have to take over the responsibility for their follow-up care. They are more prone to get lost to follow-up when no regular follow-up at an adult specialist or general practitioner is organized. However, survivors in our sample were still in the age group in which follow-up at the pediatric oncologist is usually provided. Parents of non-attenders indicated lower treatment control indicating that they were probably unaware of the importance of follow-up care. Other parents might feel follow-up appointments'; seeing a doctor when experiencing complications, (3) 'no, regular follow-up is completed, but my child goes to the treating doctor when having cancer-associated complications; and discharged, (4) 'no, regular follow-up is completed and my child has not seen the treating doctor for a while' lower treatment control, because their child has been discharged from follow-up by their pediatric oncologists, especially if the parents preferred to continue follow-up in pediatric oncology. However, our findings are in line with other studies showing that lack of knowledge might prevent survivors from seeking and receiving long-term medical or psychosocial follow-up care [7, [26] [27] [28] . To enhance care, they suggested self-advocacy training for survivors and primary care physicians [27] .
Results from the USA showed that parents with a low perceived likelihood of their child developing late effects did not try to seek more information and were unlikely to attend follow-up [29] . We found no associations with any sociodemographic or clinical variables, which were in line with another study [13] . In contrast to other studies, which showed that follow-up attendance increased with severity of late effects [8] , we found no difference by cancer diagnosis, parentreported late effects, or relapse even though riskadapted follow-up care were indicated. Among young children, parental involvement at medical visits is expected. In a recent study, mothers reported that the most important reason was concern for child's health and well-being. [12] . They also reported that it is a parental duty to accompany and support their child. This duty is of great importance in the younger age group where parents together with healthcare providers are responsible to motivate the child to stay in follow-up. In addition, they help their child to become aware of their former disease and teach them the importance of early screening and detection of late effects. Parents were more likely to be involved if they thought that their child experiences symptoms as a consequence of the cancer and if they had greater concerns about the consequences of the illness. This Fig. 2 Follow-up attendance calculated from Kaplan-Meier estimation stratified by child's age at diagnosis. The probability of follow-up attendance over time since diagnosis (years) stratified by the child's age at diagnosis: 0-1 years, 2-4 years, and 5+ years indicates that parents' overall understanding of the disease led to greater involvement. In a previous study, we showed that many parents had information needs especially on the domains follow-up care and late effects [20] . Current analyses indicated that especially parents with high overall information needs were involved in follow-up care. An important reason might be that parents want to stay involved to reassure themselves and to discuss their worries and concerns in the specialist environment. A qualitative study from England suggested that parental involvement is not only important for young survivors but also for older age groups; [30] other studies showed that parents remained involved in adult care because they remained concerned about cancer recurrence and overall health [13, 14] . Parental involvement was also reported to be very important in other chronic disease states. A study in children with diabetes showed that parental involvement was associated with improved maintenance and treatment adherence in disease management [31] . A different study in early obesity treatment showed that parental involvement was significantly higher in those who lost weight [32] . A limitation of this study is selection bias because parents of specific groups may have been more reluctant to complete the questionnaire; others may have been excluded because they did not complete the baseline questionnaire. Additionally, we only contacted one parent, mostly mothers, and thus information about involvement of the other parent is lacking. Also, details about parental involvement in follow-up care were lacking. This also explains the large difference in numbers of male and female participants. Another limitation is self-reporting bias: parents might have forgotten the frequency of appointments or did not correctly recall the information and with the lack of medical record review we could not verify if children were officially discharged. Another limitation is the cross-sectional design preventing the analysis change in treatment control. It thus remains unclear if low perceived treatment control is a cause or consequence of being discharged. The small sample size resulted in reduced accuracy for estimating effect sizes and therefore in large 95 % confidence intervals. Therefore, only limited stratification of results was possible and only a few variables could be included in the final multivariable models.
A major strength is the population-based sample of parents of childhood cancer survivors with prospectively collected data on the clinical variables of their children from the SCCR and data available from the follow-up questionnaire from the SCCSS. The response rate was good (67 %).
To improve follow-up attendance and parents' support of children, parents' beliefs should be strengthened through contact with other survivors and parents or healthcare professionals, emphasizing the importance of follow-up care. This might be especially important during and after transition to adult care. Researchers together with healthcare providers should organize regular meetings updating parents and survivors about potential late effects and give them the opportunity to meet and exchange their experiences. Each survivor and parents of young survivors should receive a personal passport for care and/or specific brochures detailing recommendations of ongoing screening. Such a passport was shown to be effective in survivors to improve knowledge of late effects and to see the benefits of long-term follow-up. [33] [34] [35] . Additionally, transition to adult care should be improved and more uniformly organized. Only if parents and survivors have the knowledge about effectiveness of follow-up care and are given adequate information throughout the cancer trajectory, will survivors reaching adulthood be able to take over responsibility of their own health and attend follow-up care visits independently even a long time after treatment has ended [7, 9, 36] . Longer duration since diagnosis is associated with lower follow-up attendance, and most parents who have information needs regarding the cancer disease of their child are involved in follow-up visits. Educating survivors and their parents on the importance and effectiveness of follow-up care might increase attendance in the longer term.
